FDA pauses advanced coronavirus vaccine trial, but not due to safety concerns
The Food and Drug Administration has paused a vaccine trial that reached Phase 2/3 of human testing, Inovio’s INO-4800 experimental drug. This is the second …
INO-4800
Latest INO-4800
Inovio’s coronavirus vaccine candidate delivers promising results in Phase 1 trial
Inovio released a coronavirus vaccine update to announce that its experimental DNA drug generated immune responses in 94% of volunteers enrolled in Phase 1 trials. …
